+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Injection Pen Market

  • PDF Icon

    Report

  • 345 Pages
  • February 2022
  • Region: Global
  • Future Market Insights
  • ID: 5578968
A recent market study on the market offers global industry analysis for 2014-2021 & opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the more important market dynamics.

After conducting thorough research on the historical and current growth parameters of the Injection Pen Market, the growth prospects of the market are obtained with maximum precision.

Market Segmentation


The Injection Pen Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.

By Product

  • Disposable Injection Pens
  • Reusable Injection Pens

By Therapy

  • Diabetes
  • Growth Hormone
  • Osteoporosis
  • Fertility
  • Auto-immune Diseases
  • Cancer
  • Other Therapies

By End User

  • Home-care Settings
  • Hospitals & Diagnostic Clinics

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Fact.MR Analysis and Recommendations
2. Market Overview
2.1. Market Coverage/Taxonomy
2.2. Market Definition/Scope/Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Injection Pen
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Injection Pen Market, by Key Countries
4.2. Injection Pen Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Injection Pen Market Demand Analysis 2015-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2015-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Injection Pen Market Value Analysis 2015-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Mn) Analysis, 2015-2021
7.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032, By Product Type
8.1. Introduction/Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type , 2015-2021
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type , 2022-2032
8.3.1. Disposable Injection Pens
8.3.2. Reusable Injection Pens
8.4. Market Attractiveness Analysis By Product Type
9. Global Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032, By Therapy
9.1. Introduction/Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Therapy , 2015-2021
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Therapy , 2022-2032
9.3.1. Diabetes
9.3.1.1. Insulin therapy
9.3.1.2. GLP-1 therapy
9.3.2. Growth Hormone
9.3.3. Osteoporosis
9.3.4. Fertility
9.3.5. Auto-immune Diseases
9.3.6. Cancer
9.3.7. Other Therapies
9.4. Market Attractiveness Analysis By Therapy
10. Global Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032, By End-Use
10.1. Introduction/Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End-Use, 2015-2021
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-Use, 2022-2032
10.3.1. Home-care Settings
10.3.2. Hospitals & Diagnostic Clinics
10.4. Market Attractiveness Analysis By End-Use
11. Global Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2021
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2022-2032
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product Type
12.4.3. By End-Use
12.4.4. By Therapy
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product Type
12.5.3. By End-Use
12.5.4. By Therapy
13. Latin America Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product Type
13.4.3. By End-Use
13.4.4. By Therapy
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product Type
13.5.3. By End-Use
13.5.4. By Therapy
14. Europe Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product Type
14.4.3. By End-Use
14.4.4. By Therapy
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By End-Use
14.5.4. By Therapy
15. Asia Pacific Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product Type
15.4.3. By End-Use
15.4.4. By Therapy
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By End-Use
15.5.4. By Therapy
16. Middle East and Africa Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2021
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product Type
16.4.3. By End-Use
16.4.4. By Therapy
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By End-Use
16.5.4. By Therapy
17. Key Countries Injection Pen Market Analysis 2015-2021 and Forecast 2022-2032
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Injection Pen Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.2.2.1. By Product Type
17.2.2.2. By End-Use
17.2.2.3. By Therapy
17.3. Canada Injection Pen Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.3.2.1. By Product Type
17.3.2.2. By End-Use
17.3.2.3. By Therapy
17.4. Mexico Injection Pen Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.4.2.1. By Product Type
17.4.2.2. By End-Use
17.4.2.3. By Therapy
17.5. Brazil Injection Pen Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.5.2.1. By Product Type
17.5.2.2. By End-Use
17.5.2.3. By Therapy
17.6. Germany Injection Pen Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.6.2.1. By Product Type
17.6.2.2. By End-Use
17.6.2.3. By Therapy
17.7. France Injection Pen Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.7.2.1. By Product Type
17.7.2.2. By End-Use
17.7.2.3. By Therapy
17.8. Italy Injection Pen Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.8.2.1. By Product Type
17.8.2.2. By End-Use
17.8.2.3. By Therapy
17.9. BENELUX Injection Pen Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.9.2.1. By Product Type
17.9.2.2. By End-Use
17.9.2.3. By Therapy
17.10. UK Injection Pen Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.10.2.1. By Product Type
17.10.2.2. By End-Use
17.10.2.3. By Therapy
17.11. Nordic Countries Injection Pen Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.11.2.1. By Product Type
17.11.2.2. By End-Use
17.11.2.3. By Therapy
17.12. China Injection Pen Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.12.2.1. By Product Type
17.12.2.2. By End-Use
17.12.2.3. By Therapy
17.13. Japan Injection Pen Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.13.2.1. By Product Type
17.13.2.2. By End-Use
17.13.2.3. By Therapy
17.14. South Korea Injection Pen Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.14.2.1. By Product Type
17.14.2.2. By End-Use
17.14.2.3. By Therapy
17.15. GCC Countries Injection Pen Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.15.2.1. By Product Type
17.15.2.2. By End-Use
17.15.2.3. By Therapy
17.16. South Africa Injection Pen Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.16.2.1. By Product Type
17.16.2.2. By End-Use
17.16.2.3. By Therapy
17.17. Turkey Injection Pen Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2015-2032
17.17.2.1. By Product Type
17.17.2.2. By End-Use
17.17.2.3. By Therapy
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. NOVO NORDISK A/S
19.3.1.1. Overview
19.3.1.2. Product Portfolio
19.3.1.3. Sales Footprint
19.3.1.4. Strategy Overview
19.3.2. BECTON, DICKINSON AND COMPANY
19.3.2.1. Overview
19.3.2.2. Product Portfolio
19.3.2.3. Sales Footprint
19.3.2.4. Strategy Overview
19.3.3. YPSOMED HOLDING AG
19.3.3.1. Overview
19.3.3.2. Product Portfolio
19.3.3.3. Sales Footprint
19.3.3.4. Strategy Overview
19.3.4. SANOFI
19.3.4.1. Overview
19.3.4.2. Product Portfolio
19.3.4.3. Sales Footprint
19.3.4.4. Strategy Overview
19.3.5. ELI LILLY AND COMPANY
19.3.5.1. Overview
19.3.5.2. Product Portfolio
19.3.5.3. Sales Footprint
19.3.5.4. Strategy Overview
19.3.6. MERCK KGAA
19.3.6.1. Overview
19.3.6.2. Product Portfolio
19.3.6.3. Sales Footprint
19.3.6.4. Strategy Overview
19.3.7. ASTRAZENECA
19.3.7.1. Overview
19.3.7.2. Product Portfolio
19.3.7.3. Sales Footprint
19.3.7.4. Strategy Overview
19.3.8. HOFFMANN-LA ROCHE LTD
19.3.8.1. Overview
19.3.8.2. Product Portfolio
19.3.8.3. Sales Footprint
19.3.8.4. Strategy Overview
19.3.9. OWEN MUMFORD
19.3.9.1. Overview
19.3.9.2. Product Portfolio
19.3.9.3. Sales Footprint
19.3.9.4. Strategy Overview
19.3.10. SULZER LTD
19.3.10.1. Overview
19.3.10.2. Product Portfolio
19.3.10.3. Sales Footprint
19.3.10.4. Strategy Overview
20. Assumptions and Acronyms Used21. Research Methodology

Companies Mentioned

  • Novo Nordisk A/S (Denmark)
  • Becton
  • Dickinson and Company (US)
  • Ypsomed Holding AG (Switzerland)
  • Sanofi (France)
  • Eli Lilly and Company (US)
  • Merck Kgaa (Germany)
  • Astrazeneca plc (Uk)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Owen Mumford (Uk)
  • Sulzer Ltd. Sun Pharmaceutical Industries Ltd. (India)
  • Pfizer (US)
  • Biocon Ltd. (India)
  • Lupin Ltd. (India)
  • Wockhardt Ltd. (India)
  • Aptargroup Inc. (The Us).